Bevacizumab and anaemia Patient Reports February 10, 2012

Bevacizumab Side Effects Report #5975892-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 17, 2008. Male patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5987857-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 24, 2008. Male patient was diagnosed with renal cell carcinoma, pain

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with INTERFERON ALFA, CEFIXIME CHEWABLE, CEFOTAXIM, FLUCONAZOLE, PANTOPRAZOLE, CREMAFFIN, TRAMADOL, ACETAMINOPHEN. Patient died on 11/10/2008.

Bevacizumab Side Effects Report #6047271-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 11, 2008. Male patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, retroperitoneal haematoma, tumour haemorrhage. Bevacizumab dosage: 730 MG, Q2W. During the same period patient was treated with INTERFERON ALFA, TEMSIROLIMUS, OMEPRAZOLE, TRAMADOL, VALIUM, PERFALGAN, PANTOPRAZOL, DURAGESIC. Patient recovered.

Bevacizumab Side Effects Report #5994097-5
Bevacizumab side effect was reported by a Physician from SPAIN on Dec 10, 2008. Male patient, weighting 162.3 lb, was diagnosed with renal cancer, prophylaxis of nausea and vomiting, pain

, hiatus hernia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, TRAMADOL, INTERFERON ALFA, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6010853-1
Bevacizumab side effect was reported by a Physician from SPAIN on Dec 17, 2008. Male patient, weighting 162.3 lb, was diagnosed with renal cancer, prophylaxis of nausea and vomiting, pain

, hiatus hernia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, TRAMADOL, INTERFERON ALFA, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6025575-0
Bevacizumab side effect was reported by a Physician from SPAIN on Dec 29, 2008. Male patient, weighting 162.3 lb, was diagnosed with renal cancer, prophylaxis of nausea and vomiting, pain

, hiatus hernia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, retroperitoneal haemorrhage. Bevacizumab dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, TRAMADOL, INTERFERON ALFA, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6125913-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 05, 2009. Male patient was diagnosed with renal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: unknown. During the same period patient was treated with TEMSIROLIMUS. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5842264-3
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on July 29, 2008. Male patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, hypertension, neutrophil count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, ISOVORIN, PARIET, LOXOPROFEN, OXYCONTIN, KYTRIL, DEXAMETHASONE PHOSPHATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5966854-2
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Nov 14, 2008. Male patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, epistaxis. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, ISOVORIN, RABEPRAZOLE, LOXOPROFEN, OXYCONTIN, KYTRIL, DEXAMETHASONE PHOSPHATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5353066-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 29, 2007. Male patient, weighting 154.3 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, gastroenteritis

. Bevacizumab dosage: 350 MG, UNK. During the same period patient was treated with FLUOROURACIL, IRINOTECAN, CALCIUM FOLINATE, NOVAMINSULFON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5977884-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 18, 2008. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, gastric ulcer, haemorrhage. Bevacizumab dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, CAMPTOSAR, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5166002-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2006. Male patient, 71 years of age, was diagnosed with prostate cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, aortic valve incompetence, atrial fibrillation

, dilatation ventricular, haematochezia, mitral valve incompetence, neutropenia, pulmonary valve incompetence, rectal haemorrhage. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, PREDNISONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5301949-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 16, 2007. Male patient, weighting 220.0 lb, was diagnosed with prostate cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dizziness

, dyspnoea exertional, dysstasia, faeces discoloured, nausea

, presyncope, pyrexia. Bevacizumab dosage: 1500 MG Q THREE WEEKS IV DRIP. During the same period patient was treated with ERLOTINIB, AVASTIN, TAXOTERE, PREDNISONE, TARCEVA, ACTOPLUS, ASPIRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5990020-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 09, 2008. Male patient, 70 years of age, weighting 154.3 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, haematochezia. Bevacizumab dosage: 750MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5335224-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 22, 2007. Female patient, 67 years of age, weighting 97.00 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with ERLOTINIB, GEMCITABINE, AMBIEN, ACETYLSALICYLIC ACID SRT, COMPAZINE, CREON, LIPITOR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6032646-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 07, 2009. Male patient, 67 years of age, weighting 130.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 10MG / KGIV, D1+15 28 DAY. During the same period patient was treated with GEMCITABINE, FLUOROURACIL, ACIPHEX, ASPIRIN, CREON, IMODIUM A, LOMOTIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5749731-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 22, 2008. Female patient, 46 years of age, weighting 154.3 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, back pain

, constipation

. Bevacizumab dosage: 710MG Q2WKS IV. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5941580-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Female patient, 46 years of age, weighting 70.00 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, back pain

, constipation

, spinal compression fracture. Bevacizumab dosage: 710 MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5948725-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 03, 2008. Female patient, 46 years of age, weighting 154.3 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, back pain

. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5917032-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2008. Male patient, 43 years of age, weighting 152.1 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, pancreatitis. Bevacizumab dosage: 720MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, TAXOTERE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5469617-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 25, 2007. Female patient, weighting 99.21 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, fatigue, gastrointestinal haemorrhage, syncope. Bevacizumab dosage: 480MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient recovered.

Bevacizumab Side Effects Report #5934853-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 20, 2008. Female patient, weighting 151.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, vomiting. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, RAMIPRIL, LEVOTHYROXINE, FUROSEMID, DIGITOXIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5952511-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 30, 2008. Female patient, weighting 123.5 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, cholangitis, stent occlusion. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6049249-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 15, 2009. Male patient, 67 years of age, weighting 130.0 lb, was diagnosed with pancreatic carcinoma, pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with GEMCITABINE, FLUOROURACIL, ACIPHEX, ASPIRIN, CREON, IMODIUM, LOMOTIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5984635-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 25, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, leukopenia. Bevacizumab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient recovered.

Bevacizumab Side Effects Report #6014951-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 05, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, leukopenia, urogenital fistula. Bevacizumab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient recovered.

Bevacizumab Side Effects Report #6049215-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 08, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, leukopenia, urogenital fistula. Bevacizumab dosage: 576 MG, UNK. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient recovered.

Bevacizumab Side Effects Report #5518137-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Female patient, 70 years of age, weighting 134.5 lb, was diagnosed with ovarian cancer metastatic, ovarian cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, intestinal obstruction, neutropenia, thrombocytopenia. Bevacizumab dosage: 10MG/1 D KG DAYS 1, 15. During the same period patient was treated with HYCAMTIN, CALCIUM, SYNTHROID, GLUCOSAMINE, VYTORIN, ATENOLOL, COMPAZINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5690884-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 27, 2008. Female patient, weighting 149.7 lb, was diagnosed with ovarian cancer, deep vein thrombosis

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 680 MG, Q2W. During the same period patient was treated with ERLOTINIB, COUMADIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5884254-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 08, 2008. Male patient, weighting 186.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, leukopenia, oesophagitis. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, RADIATION, ZOFRAN, PROTONIX, PERCOCET. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4967125-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis, blood pressure increased, confusional state, convulsion, hypertension, hypertensive encephalopathy, hypokalaemia, malignant neoplasm progression. Bevacizumab dosage: unknown. During the same period patient was treated with PACILTAXEL, ACETAMINOPHEN, LABETALOL, ROCEPHIN, TOPROL, LISINOPRIL, AMPICILLIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5252909-7
Bevacizumab side effect was reported by a Physician from FRANCE on Feb 07, 2007. Female patient, 58 years of age, weighting 165.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, condition aggravated, disease progression, hypertension, international normalised ratio increased, thrombosis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, LOVENOX, RABEPRAZOLE, ATACAND, ATENOLOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4999865-4
Bevacizumab side effect was reported by a Physician from FRANCE on Apr 21, 2006. Female patient, 58 years of age, weighting 165.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, thrombosis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, RABEPRAZOLE, ATACAND, LOXEN, INNOHEP, EMEND, VOGALENE. Patient was hospitalized. Patient died.

Bevacizumab Side Effects Report #5296017-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Female patient, weighting 133.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, constipation

, nausea

, fatigue. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, REGLAN, PROCRIT. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5321890-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 27, 2007. Female patient, weighting 99.21 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5351069-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 01, 2007. Female patient, weighting 133.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, constipation

, nausea

. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5373991-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 19, 2007. Female patient, weighting 143.7 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood urea increased, gastric ulcer, gastrointestinal haemorrhage, protein total decreased, white blood cell count increased. Bevacizumab dosage: 975 MG, Q3W. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, NORVASC, PRILOSEC, SPIRIVA, ALBUTEROL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5387633-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 06, 2007. Female patient, weighting 150.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dehydration, dizziness

, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA, CARBOPLATIN, RADIATION. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5392578-9
Bevacizumab side effect was reported by a Physician from FRANCE on July 05, 2007. Male patient, weighting 165.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, lymphocyte count decreased, neutrophil count decreased, thrombosis. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, SERETIDE, SPIRIVA, TRANXENE, LIPANTHYL, ATARAX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5394435-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 12, 2007. Female patient, weighting 107.0 lb, was diagnosed with non-small cell lung cancer, metastases to central nervous system and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: unknown. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5395518-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 19, 2007. Female patient, weighting 150.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dehydration, dizziness

, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA, CARBOPLATIN, RADIATION, FOLIC ACID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5423896-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 14, 2007. Female patient, weighting 107.0 lb, was diagnosed with non-small cell lung cancer, metastases to central nervous system, nausea

, pain

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, face injury, fall

, head injury, platelet count decreased. Bevacizumab dosage: unknown. During the same period patient was treated with ALIMTA, ATIVAN, KEPPRA, OXYCODONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5479945-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 26, 2007. Male patient, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, erosive oesophagitis. Bevacizumab dosage: 1395 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DEXAMETHASONE, REGLAN, EMEND, KYTRIL, PHENERGAN, PRILOSEC. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5485561-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 03, 2007. Male patient, weighting 185.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5487182-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 03, 2007. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5505224-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 23, 2007. Male patient, weighting 185.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5566528-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 06, 2007. Female patient, weighting 180.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Bevacizumab dosage: 1230 MG, Q3W. During the same period patient was treated with CARBOPLATIN, NAVELBINE, FENTANYL, VENDAL, ACTONEL, MEXALEN, SEROPRAM. Patient recovered.

Bevacizumab Side Effects Report #5570054-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 06, 2007. Male patient, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Bevacizumab dosage: 995 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5576849-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 13, 2007. Male patient, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Bevacizumab dosage: 995 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CISPLATIN, PANTOLOC, LASIX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5577985-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 17, 2007. Female patient, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, NAVELBINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5579224-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 20, 2007. Female patient, weighting 107.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 740 MG, Q3W. During the same period patient was treated with GEMCITABINE, TAXOTERE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5591654-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 07, 2008. Male patient, weighting 185.0 lb, was diagnosed with non-small cell lung cancer, prophylaxis, gastrooesophageal reflux disease, hypercholesterolaemia, hypertension, bone pain and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PLAVIX, NEXIUM, CRESTOR, RANEXA, NORVASC, OXYCODONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5598700-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 08, 2008. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 750 MG, Q3W. During the same period patient was treated with CARBOPLATIN, NAVELBINE, DOCETAXEL, VOLTAREN, PANTOZOL, AMITRIPTYLINE, PALLADONE, MORPHINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5611686-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 21, 2008. Female patient, weighting 99.21 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, KETOPROFEN, ACETAMINOPHEN W, NEXIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5618819-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 23, 2008. Male patient, weighting 165.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Bevacizumab dosage: 1126 MG, UNK. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5631091-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 05, 2008. Male patient, weighting 191.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 1300 MG, Q3W. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5645089-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 21, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, neutropenia. Bevacizumab dosage: 848 MG, UNK. During the same period patient was treated with ALBUTEROL, VASOTEC, POTASSIUM CHLORIDE, FOLINIC ACID, DOXYCYCLINE, BENZOYL PEROXIDE, CLINDAMYCIN LOTION, ALIMTA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5700829-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 26, 2008. Male patient, weighting 167.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with CISPLATIN, GEMCITABINE, NEBIVOLOL, ALLOPURINOL, FAMOTIDIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5703646-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 28, 2008. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 735 MG, Q3W. During the same period patient was treated with CARBOPLATIN, NAVELBINE, DICLOFENAC, HYDROMORPHONE, PANTOZOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5707361-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 01, 2008. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 750 MG, Q3W. During the same period patient was treated with CARBOPLATIN, NAVELBINE, DOCETAXEL, VOLTAREN, PANTOZOL, AMITRIPTYLINE, PALLADONE, MORPHINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5725717-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 22, 2008. Female patient, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, fatigue, neutrophil count decreased, pyrexia. Bevacizumab dosage: 480 MG, Q3W. During the same period patient was treated with BISOPROLOL FUMARATE, COZAAR, AMLODIPINE, SPIRON, FUROSEMIDE, SIMVASTATIN, NEXIUM, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5759292-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 20, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 1040 MG, Q3W. During the same period patient was treated with GEMZAR, CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5760079-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 23, 2008. Male patient, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 405 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, SEROPRAM, ATARAX, XANAX, DUPHALAC, TRAMADOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5762589-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 26, 2008. Male patient, weighting 191.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 1300 MG, Q3W. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5792249-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 11, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 1040 MG, Q3W. During the same period patient was treated with GEMZAR, CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5812276-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 01, 2008. Female patient, weighting 94.80 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased. Bevacizumab dosage: 700 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, CARBOPLATIN, KETOPROFEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5858852-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 13, 2008. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 750 MG, Q3W. During the same period patient was treated with CARBOPLATIN, NAVELBINE, DOCETAXEL, VOLTAREN, PANTOZOL, AMITRIPTYLINE, PALLADONE, MORPHINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5875646-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 25, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 10/05/2007.

Bevacizumab Side Effects Report #5914067-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 01, 2008. Female patient, weighting 133.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with ALIMTA, GEMZAR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5926658-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 16, 2008. Female patient, weighting 133.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with ALIMTA, GEMZAR, AMLODIPINE, OXYBUTYNIN, ASPIRIN, FOLIC ACID, NEXIUM, ATARAX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5929928-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased, hypoproteinaemia, pneumonia

. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 10/05/2007.

Bevacizumab Side Effects Report #5944151-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased, hypoproteinaemia, pneumonia

. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6005046-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 08, 2008. Male patient, weighting 173.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dizziness

, hallucination. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ALIMTA, GEMZAR, ASPIRIN, COMPAZINE, TENORMIN, FOLIC ACID, MILK OF MAGNESIA, DULCOLAX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6092784-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 10, 2009. Male patient, weighting 191.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 1300 MG, Q3W. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5958543-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with metastatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, IRINOTECAN HYDROCHLORIDE. Patient recovered.

Bevacizumab Side Effects Report #5593106-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Male patient, weighting 176.4 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, anaemia, gastrointestinal haemorrhage, vomiting. Bevacizumab dosage: 10MG/M2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN D. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5842321-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 30, 2008. Female patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 305 MG, QD. During the same period patient was treated with ERLOTINIB, DOLCET. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6098983-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 16, 2009. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, MOSEGOR, TRAMADOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6115721-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 26, 2009. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, MOSEGOR, TRAMADOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6132536-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 10, 2009. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, melaena. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, MOSEGOR, TRAMADOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5062789-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2006. Male patient, weighting 190.0 lb, was diagnosed with endocrine neoplasm, pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, anaemia, asthenia, fatigue, gastritis erosive, ileus, liver abscess, platelet count decreased, pyrexia. Bevacizumab dosage: 465 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5777949-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 18, 2008. Female patient, 70 years of age, weighting 156.5 lb, was diagnosed with disease recurrence, neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, atelectasis, blood magnesium decreased, bronchitis

, loss of consciousness, white blood cell count increased. Bevacizumab dosage: 10MG/KG DAY 1+15 Q 28. During the same period patient was treated with TOPOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5425443-9
Bevacizumab side effect was reported by a Consumer or non-health professional from GERMANY on Aug 09, 2007. Female patient, weighting 154.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: 350 MG/M2, Q2W. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, NOVAMINSULFON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5446172-1
Bevacizumab side effect was reported by a Consumer or non-health professional from AUSTRALIA on Aug 23, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, renal impairment, thrombotic microangiopathy. Bevacizumab dosage: 7.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5483709-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 27, 2007. Female patient, weighting 79.37 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, weight decreased, white blood cell count decreased. Bevacizumab dosage: 4.8 MG/KG, UNK. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, ISOVORIN, VOLTAREN, HALCION, FOSAMAX, NASEA, CHINESE MEDICINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5515215-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 05, 2007. Male patient, weighting 143.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, rectal haemorrhage. Bevacizumab dosage: 325 MG, Q2W. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, TRIANAL C. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5548607-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 10, 2007. Female patient, weighting 79.37 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, weight decreased, white blood cell count decreased. Bevacizumab dosage: 4.8 MG/KG, UNK. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, ISOVORIN, VOLTAREN, HALCION, FOSAMAX, NASEA, CHINESE MEDICINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5587284-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 26, 2007. Male patient was diagnosed with colorectal cancer metastatic, proctalgia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with LOXONIN, OXALIPLATIN, FLUOROURACIL, ISOVORIN, NORVASC, ADALAT, BASEN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5615409-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2008. Male patient, weighting 192.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FENTANYL TRANSDERMAL SYSTEM, DILAUDID, COMPAZINE, HYDROCODONE BITARTRATE, ROBAXIN, ZOFRAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5670813-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 04, 2008. Female patient, weighting 79.37 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, ascites, decubitus ulcer, weight decreased, white blood cell count decreased. Bevacizumab dosage: 4.8 MG/KG, UNK. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, ISOVORIN, VOLTAREN, HALCION, FOSAMAX, NASEA, CHINESE MEDICINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5692332-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 18, 2008. Male patient was diagnosed with colorectal cancer metastatic, proctalgia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with LOXONIN, OXALIPLATIN, FLUOROURACIL, ISOVORIN, NORVASC, ADALAT, BASEN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5827304-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 22, 2008. Male patient, weighting 134.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, deep vein thrombosis

, gastrointestinal haemorrhage, oesophagitis, shock haemorrhagic. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ZOFRAN, PRILOSEC, ALTERNAGEL, LASIX. Patient was hospitalized. Patient died on 04/27/2008.

Bevacizumab Side Effects Report #6019868-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 18, 2008. Male patient, weighting 134.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, deep vein thrombosis

, gastrointestinal haemorrhage, oesophagitis, shock haemorrhagic. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ZOFRAN, PRILOSEC, ALTERNAGEL, LASIX. Patient was hospitalized. Patient died on 04/27/2008.

Bevacizumab Side Effects Report #5754293-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 23, 2008. Male patient, weighting 181.0 lb, was diagnosed with colorectal cancer

, anaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia. Bevacizumab dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, FLUOROURACIL, FOLINIC ACID, OXALIPLATIN, FERROUS SULPHATE, OXYCOCET, OXYCODONE. Patient was hospitalized. Patient recovered.

Bevacizumab and anaemia

SideEffects101.com

Bevacizumab and anaemia Patient Reports February 10, 2012

side effects of Bevacizumab